BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2737 related articles for article (PubMed ID: 23036225)

  • 21. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Developments in Liposomal Drug Delivery.
    Pattni BS; Chupin VV; Torchilin VP
    Chem Rev; 2015 Oct; 115(19):10938-66. PubMed ID: 26010257
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of injectable drug nanocrystals.
    Fuhrmann K; Gauthier MA; Leroux JC
    Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of targeted drug delivery system in Chinese medicine.
    Li DC; Zhong XK; Zeng ZP; Jiang JG; Li L; Zhao MM; Yang XQ; Chen J; Zhang BS; Zhao QZ; Xie MY; Xiong H; Deng ZY; Zhang XM; Xu SY; Gao YX
    J Control Release; 2009 Sep; 138(2):103-12. PubMed ID: 19433120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomes as nanovaccine delivery systems.
    Ghaffar KA; Giddam AK; Zaman M; Skwarczynski M; Toth I
    Curr Top Med Chem; 2014; 14(9):1194-208. PubMed ID: 24678703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
    Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N
    Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
    Baker JR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes in ultrasonic drug and gene delivery.
    Huang SL
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nanotechnology in developing new therapies for diseases of the nervous system.
    Jain KK
    Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
    [No Abstract]   [Full Text] [Related]  

  • 39. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent development of targeted drug delivery system].
    Zhou PJ; Deng SQ; Gong QF
    Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 137.